IFNβ accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to β cells in nondiabetes-prone mice

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 6667-6675

  Alba, Aurora ^a   Puertas, M Carmen ^a   Carrillo, Jorge ^a   Planas, Raquel ^a   Ampudia, Rosa ^a   Pastor, Xavier ^a   Bosch, Fatima ^b   Pujol Borrell, Ricardo ^a   Verdaguer, Joan ^a   Vives Pi, Marta ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA INTERFERON; CYTOKINE; GLUCAGON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PREPROINSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYMUS; TRANSGENIC MOUSE;

EID: 9144258464     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.6667     Document Type: Article

References (41)

1. Bach, J. F., and L. Chatenoud. 2001. Tolerance to islet autoantigens in type I diabetes. Annu. Rev. Immunol. 19:131
2. Bach, J. F. 1999. The immunology of diabetes: revolution of concepts over a decade. In The Decade of Autoimmunity, Y. Shoenfeld, ed. Elsevier, Oxford p. 149.
3. Notkins, A. L. 2002. Immunologic and genetic factors in type 1 diabetes. J. Biol. Chem. 277:4354.
4. Todd, J. A., and S. C. Bain. 1992. A practical approach to identification of susceptibility genes for IDDM. Diabetes 41:1029.
5. Jun, H. S., and J. W. Yoon. 2003. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 19:8.
6. Horwitz, M. S., A. Ilic, C. Fine, E. Rodriguez, and N. Sarvetnick. 2002. Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109:79.
7. Horwitz, M. S., C. Fine, A. Ilic, and N. Sarvetnick. 2001. Requirements for viral-mediated autoimmune diabetes: β-cell damage and immune infiltration. J. Autoimmun. 16:211.
8. Hooks, J. J., H. M. Moutsopoulos, S. A. Geis, N. I. Stahl, J. L. Decker, and A. L. Notkins. 1979. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301:5.
9. Foulis, A. K., M. A. Farquharson, and A. Meager. 1987. Immunoreactive α interferon in insulin secreting β cells in type 1 diabetes mellitus. Lancet 2:1423.
10. Somoza, N., F. Vargas, C. Roura-Mir, M. Vives-Pi, M. T. Fernandez-Figueras, A. Ariza, R. Gomis, R. Bragado, M. Marti, D. Jaraquemada, and R. Pujol-Borrell. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor Vβ usage, and cytokine profile. J. Immunol. 153:1360.
11. Huang, X., J. Yuang, A. Goddard, A. Foulis, R. F. James, A. Lernmark, R. Pujol-Borrell, A. Rabinovitch, N. Somoza, and T. A. Stewart. 1995. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44:658.
12. Stewart, T. A., B. Hultgren, X. Huang, S. Pitts-Meek, J. Hully, and N. J. MacLachlan. 1993. Induction of type I diabetes by interferon-α in transgenic mice. Science 260:1942.
13. Vassileva, G., S. C. Chen, M. Zeng, S. Abbondanzo, K. Jensen, D. Gorman, B. M. Baroudy, Y. Jiang, N. Murgolo, and S. A. Lira. 2003. Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice. J. Immunol. 170:5748.
14. Pelegrin, M., D. J. Devedjian, C. Costa, J. Visa, G. Solanes, A. Pujol, G. Asins, A. Valera, and F. Bosch. 1998. Evidence from transgenic mice that interferon-β may be involved in the onset of diabetes mellitus. J. Biol. Chem. 20:12332.
15. Iwakura, Y., M. Asano, Y. Nishimune, and Y. Kawade. 1988. Male sterility of transgenic mice carrying exogenous mouse interferon β under the control of metallothionein enhancer-promoter. EMBO J. 7:3757.
16. Makino, S., and Y. Tochino. 1978. The spontaneously nonobese diabetic mouse. Exp. Anim. 27:27.
17. Prochazca, M., D. V. Serreze, W. N. Frankel, and E. H. Leiter. 1992. NOR/LtJ mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41:98.
18. Dandoy-Dron, F., E. Monthioux, J. Jami, and D. Buchinni. 1991. Regulatory regions of rat insulin I gene necessary for expression in transgenic mice. Nucleic Acid Res. 19:4925.
19. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Leiter. 1992. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated immunodeficiency. Proc. Natl. Acad. Sci. USA 89:3290.
20. Mora, C., F. S. Wong, C. H. Chang, and R. Flavell. 1999. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J. Immunol. 162:4576.
21. Benavides, F., E. Glasscock, L. G. Coghlan, M. C. Stern, D. A. Weiss, and C. J. Conti. 2001. PCR-based microsatellite analysis for differentiation and genetic monitoring of nine inbred SENCAR mouse strains. Lab. Anim. 35:157.
22. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Leiter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161:3912.
23. Rohane, P. W., A. Shimada, D. T. Kim, C. T. Edwards, B. Charlton, L. D. Shultz, and C. G. Fathman. 1995, Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 44:550.
24. Abiru, N., L. Yu, D. Miao, A. K. Maniatis, E. Liu, H. Moriyama, and G. S. Eisenbarth. 2001. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains. J. Autoimmun. 17:1.
25. Kunzi, M. S., and P. P. Rowe. 2001. IFN-α, IFN-β and ω ligands. In Cytokine Reference, Vol. 1. S. K. Durum, T. Hirano, J. Vilcek, and N. A. Nicol, eds. Academic, Cornwall, U.K., p. 627.
26. Serreze, D. V., C. M. Post, H. D. Chapman, E. A. Johnson, B. Lu, and P. B. Rothman. 2000. Interferon γ receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 49:2007.
27. Kado, S., J. Miyamoto, N. Komatsu, Y. Iwaki, H. Ozaki, H. Taguchi, M. Kure, G. Sarashina, T. Watanabe, Y. Katsura, et al. 2000. Type 1 diabetes mellitus caused by treatment with interferon-β. Intern. Med. 39:146.
28. Wesche, B., E. Jaeckel, C. Trautwein, H. Wedemeyer, A. Falorni, H. Frank, A. von zur Muhlen, M. P. Manns, and G. Brabant. 2001. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon α therapy for chronic hepatitis C. Gut 48:378.
29. Sinigaglia, F., D. D'Ambrosio, and L. Rogge. 1999. Type I interferons and the Th1/Th2 paradigm. Dev. Comp. Immunol. 23:657.
30. Oritani, K., P. W. Kincade, C. Zhang, Y. Tomiyama, and Y. Matsuzawa. 2001. Type I interferons and limitin: a comparison of structures, receptors, and functions. Cytokine Growth Factor Rev. 12:337.
31. Ablamunits, V., D. Elias, and I. R. Cohen. 1999. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Clin. Exp. Immunol. 115:260.
32. Roche, E. F., H. Lewy, H. M. Hoey, and Z. Laron. 2003. Differences between males and females in the seasonality of birth and month of clinical onset of disease in children with type 1 diabetes mellitus in Ireland. J. Pediatr. Endocrinol. Metab. 16:779.
33. Hyoty, H., and K. W. Taylor. 2002. The role of viruses in human diabetes. Diabetologia 45:1353.
34. Lipman, T. H., Y. Chang, and K. M. Murphy. 2002. The epidemiology of type 1 diabetes in children in Philadelphia 1990-1994: evidence of an epidemic. Diabetes Care 25:1969.
35. Vives, M., N. Somoza, F. Vargas, and R. Pujol-Borrell. 1995. Overexpression of MHC proteins in pancreatic islets: a link between cytokines, viruses, breach of tolerance and insulin dependent diabetes mellitus. In Modulation of MHC Antigen Expression and Disease. E. D. Blair, C. R. Pringle, and D. J. Maudsley, eds. Cambridge Univ. Press, Cambridge, U.K., p. 361.
36. Redwine, J. M., M. J. Buchmeier, and C. F. Evans. 2001. In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am. J. Pathol. 159:1219.
37. Dhib-Jalbut, S. S., and E. P. Cowan. 1993. Direct evidence that interferon-β mediates enhanced HLA-class I expression in measles virus-infected cells. J. Immunol. 151:6248
38. Herberts, C. A., J. van Gaans-van den Brink, E. van der Heeft, M. van Wijk, J. Hoekman, A. Jaye, M. C. Poelen, C. J. Boog, P. J. Roholl, H. Whittle, et al. 2003. Autoreactivity against induced or upregulated abundant self-peptides in HLA-A*0201 following measles virus infection. Hum. Immunol. 64:44.
39. Christen, U., D. Benke, T. Wolfe, E. Rodrigo, A. Rhode, A. C. Hughes, M. B. A. Oldstone, and M. G. von Herrath. 2004. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest. 113:74.
40. Rabinovitch, A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14:129.
41. Hänninen, A., E. Hamilton-Williams, and C. Kurts. 2003. Development of new strategies to prevent type 1 diabetes: the role of animal models. Ann. Med. 35:546.